Study tracking DNA from tumors in advanced ovarian cancer
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with advanced ovarian cancer (stage 3 or higher), or cancer of the fallopian tubes or lining of the abdomen.
- You are between 18 and 80 years old.
- You have not had any other cancer in the last 5 years.
- You have not had chemotherapy or other targeted cancer treatments yet.
- You are not pregnant or breastfeeding.
- You are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood samples from people with ovarian cancer to measure a marker called ctDNA (bits of tumor DNA in the blood). The goal is to see if changes in this marker before and after surgery can help predict or monitor the cancer.
This trial uses a small piece of your cancer tissue (taken during surgery) to grow 'mini-tumors' in the lab. These help doctors find which treatments might work best for you. It is for people with advanced serous ovarian cancer.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study looks at certain “DNA repair traits” (called homologous recombination phenotype) in people with epithelial ovarian cancer. Results may help researchers better understand who responds to platinum chemotherapy, which is commonly used for this cancer.
This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.